Dr Reddy's Laboratories's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; and it has a dividend yield of 0.57%. Dr Reddy's Laboratories is scheduled to report earnings on May 22, 2024, and the estimated EPS forecast is $0.90. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	₹ 67.70B	₹ 63.06B	₹ 52.15B	₹ 54.37B
Gross Profit	-	₹ 40.09B	₹ 37.25B	₹ 26.01B	₹ 28.74B
EBIT	-	₹ 16.77B	₹ 16.42B	₹ 15.00B	₹ 2.80B
EBITDA	-	₹ 16.77B	₹ 19.55B	₹ 18.05B	₹ 5.76B
Net Income Common Stockholders	-	₹ 12.47B	₹ 11.13B	₹ 11.88B	₹ 875.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	₹ 66.50B	₹ 50.16B	₹ 27.57B	₹ 34.34B	₹ 44.37B
Total Assets	₹ 321.85B	-	₹ 290.97B	₹ 295.98B	₹ 292.83B
Total Debt	₹ 6.08B	₹ 0.00	₹ 17.29B	₹ 24.67B	₹ 33.84B
Net Debt	₹ -60.42B	₹ -50.16B	₹ -10.29B	₹ -9.68B	₹ -10.52B
Total Liabilities	₹ 95.13B	-	₹ 84.75B	₹ 95.59B	₹ 102.30B
Stockholders Equity	₹ 226.72B	₹ 220.27B	₹ 206.22B	₹ 200.39B	₹ 190.53B
Cash Flow	-
Free Cash Flow	-	₹ 20.16B	₹ 5.95B	₹ -2.04B	₹ 5.09B
Operating Cash Flow	-	₹ 23.26B	₹ 9.28B	₹ 6.66B	₹ 9.12B
Investing Cash Flow	-	₹ -26.41B	₹ 5.73B	₹ -4.92B	₹ -21.99B
Financing Cash Flow	-	₹ 583.00M	₹ -12.35B	₹ -10.80B	₹ 5.10B

Currency in INR

Dr Reddy's Laboratories Earnings and Revenue History

Income Statement >

Dr Reddy's Laboratories Debt to Assets

Balance Sheet >

Dr Reddy's Laboratories Cash Flow

Cash Flow >

Dr Reddy's Laboratories Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing